Ints7 deficiency activates DNA damage response to elicit resurgence of endogenous retrovirus MERVL and anastasis of embryonic stem cells
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Yunfan Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Genetics, School of Life Sciences & Hunan Key Laboratory of Molecular Precision Medicine, Department of Oncology, Xiangya Hospital…. Hauptthemen laut MEDLINE: DNA Damage, Endogenous Retroviruses, Mouse Embryonic Stem Cells, DNA-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Department of Science & Technology of Hunan Province, Central South University.
Abstract (Originalsprache)
The murine endogenous retrovirus MERVL is dynamically activated in a small population of in vitro cultured mouse embryonic stem cells (mESCs) exhibiting totipotent-like features. Yet, the relationship between MERVL activation and cell fate decisions of mESCs is incompletely understood. Through a genome-wide knockout screen, we discovered that MERVL activity is intrinsically linked to DNA damage response pathways. Loss of Ints7, a backbone subunit of the Integrator complex, increased DNA damage and triggered MERVL expression. Mechanistically, Ints7 depletion induced phosphorylation of Kap1, increased chromatin accessibility at MERVL loci, and activated the p53–Dux axis to drive MERVL transcription. Intriguingly, DNA damage-induced MERVL resurgence followed the cleavage of caspase-3, often accompanying a process known as anastasis—cell survival after transient apoptotic signaling. Collectively, our study uncovered that MERVL activation in mESCs is integrated into the cellular circuit for decision-making in response to DNA damage, suggesting that sublethal caspase activation can influence the developmental potential of stem cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Medical Genetics, School of Life Sciences & Hunan Key Laboratory of Molecular Precision Medicine, Department of Oncology, Xiangya Hospital, Central South University, Changsha 410000, China.
- Department of Reproductive Medicine, Xiangya Hospital, Central South University, Changsha 410000, China.
- Key Laboratory of Experimental Teratology, Ministry of Education, Department of Histoembryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
- Furong Laboratory, Central South University, Changsha 410000, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha 410000, China.
- The Biobank of Xiangya Hospital, Central South University, Changsha 410000, China.
ORCID-Profile: Kai Yuan
Förderung
- National Natural Science Foundation of China
- Department of Science & Technology of Hunan Province
- Central South University
Zitieren
APA
Shen, Y., Li, L., Ni, H., Li, H., Xu, M., Tan, X., Li, Z., Li, P., Chen, F., Mao, S., Sun, G., & Yuan, K. (2025). Ints7 deficiency activates DNA damage response to elicit resurgence of endogenous retrovirus MERVL and anastasis of embryonic stem cells. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf797
Vancouver
Shen Y, Li L, Ni H, Li H, Xu M, Tan X, et al. Ints7 deficiency activates DNA damage response to elicit resurgence of endogenous retrovirus MERVL and anastasis of embryonic stem cells. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf797
BibTeX
@article{Shen2025,
author = {Shen, Yunfan and Li, Li and Ni, Huiling and Li, Hui and Xu, Mingrui and Tan, Xiaoyang and Li, Zhangjie and Li, Pishun and Chen, Fang and Mao, Song and Sun, Gongping and Yuan, Kai},
title = {Ints7 deficiency activates DNA damage response to elicit resurgence of endogenous retrovirus MERVL and anastasis of embryonic stem cells},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf797}
}
EUVIMED